- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06891612
Electroencephalographic Study of the Mechanisms of Inhibition of Emotional Memories in Young Healthy Subjects (ENGRAMME)
Etude Par électroencéphalographie Des mécanismes d'Inhibition de Souvenirs émotionnels Chez le Sujet Jeune Sain
Forgetfulness has long been considered a pathology of memory. However, the brain's voluntary suppression of certain unpleasant memories is essential for building a healthy memory. This suppression capacity can be measured using the "Think/No-Think" (TNT) paradigm.However, while the areas involved in these processes of suppression are now well described, the nature and temporal dynamics of the processes of inhibition and orientation of attention is still poorly defined. The aim of this study is to describe the nature of the attentional and inhibitory mechanisms involved in the suppression of emotionally negative memories, and their temporal articulation using electroencephalography (EEG). To this end, we will use a model of memory deletion derived from a perceptual attentional task and simulating the deletion phase in order to control the nature and timing of the processes involved. This approach will allow us to observe the presence of correspondences between the responses measured during the attentional test simulating the suppression and the actual phase of suppression, for which we cannot control the nature of the operations undertaken by the subject. In addition, we will assess the emotional response through physiological measures of autonomic nervous system activity (heart rate and electrodermal response) immediately after the TNT phase or one day later, which will allow us to evaluate the influence of memory suppression mechanisms on their emotional content.
From a practical point of view, this study is organized into 3 groups of participants (healthy young adults). Each group will perform a perceptual attentional test and a TNT task, which will be preceded and followed by a measure of emotional response. Group 1 will allow us to test our main hypothesis from a behavioral point of view, as well as to calibrate the attentional task and its consistency with the TNT task. Group 2 will carry out the same tests but during an EEG examination to decode the temporal dynamics of attention states during the process of memory suppression. Group 3 will perform these same tests with a 24-hour interval between the TNT phase and the emotional assessment to estimate the effect of a retention period on forgetfulness functions.
The description of these mechanisms and their physiological correlates will allow us to better understand how this ability to voluntarily control the flow of thoughts associated with negative memories is implemented, and thus to better understand the alterations in this capacity that can be observed during certain mental pathologies such as anxiety or depression.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Caen, France, 140330 Caen Cedex 9
- Service de neurologie CHU de Caen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male or female aged between 18 and 35 years
- Affiliated to a social security scheme
- Having French as their mother tongue
- Right-handed
- High school graduate or equivalent
- Having signed a written informed consent
Exclusion Criteria:
- Pregnancy in progress, pregnancy test will be performed
- Person deprived of liberty by judicial or administrative decision
- Person hospitalized without consent and not subject to legal protection measures, and person admitted to a health or social care facility for purposes other than research
- Minor
- Adults subject to legal protection measure (guardianship, curatorship or judicial protection), adults unable to express their consent and not subject to protection measure
- Person subject to an exclusion for another research
- History of a neurological, psychiatric disorders, or head trauma with loss of consciousness for more than an hour
- History of cancer over the last 5 years, with the exception of squamous cell carcinomas of the skin
- Presence or history of chronic alcoholism or drug addiction
- Taking medications that may alter cognitive and/or brain function (decision of the principal investigator)
- Presence of visual and/or auditory disorders sufficiently significant to affect the progress of the tests
- Contraindications to electroencephalography
- Presentation of unpleasant images that are too emotionally disturbing for the participant (by decision of the physician)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: pretest healthy participants
|
Cognitive Assessments
measurement of the points of gaze
Electrophysiological monitoring method to record electrical activity of the brain
measurement of the electrical activity of the heart
|
|
Experimental: healthy participant 10 min delayed recall
10 min delayed recall
|
Cognitive Assessments
measurement of the points of gaze
Electrophysiological monitoring method to record electrical activity of the brain
measurement of the electrical activity of the heart
|
|
Experimental: healthy participant 24 h delayed recall
24 h delayed recall
|
Cognitive Assessments
measurement of the points of gaze
Electrophysiological monitoring method to record electrical activity of the brain
measurement of the electrical activity of the heart
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Completion psychopathological scales
Time Frame: Inclusion visit
|
Entered into a computer
|
Inclusion visit
|
|
Measurement of the electrodermal conductance
Time Frame: Day1
|
For emotional evaluation when presenting negative images
|
Day1
|
|
Measuremet of heart rate
Time Frame: Day 1
|
For emotional evaluation when presenting negative images
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attentional task
Time Frame: Day 1 and Day 2
|
This test is performed on a computer after learning pairs of images
|
Day 1 and Day 2
|
|
Test of "Think/No-Think"
Time Frame: Day1 and Day2
|
This test is performed on a computer after learning pairs of images
|
Day1 and Day2
|
|
Measurement of the electrodermal conductance
Time Frame: Day 1 and Day 2
|
For emotional evaluation after learning pairs of images
|
Day 1 and Day 2
|
|
Measuremet of heart rate
Time Frame: Day 1 and Day 2
|
For emotional evaluation after learning pairs of images
|
Day 1 and Day 2
|
|
Measurement of electroencephalographic activity
Time Frame: Day1 and Day 2
|
Subjects will be equiped with electrodes during the attentional task and " Think/No-Think " test
|
Day1 and Day 2
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Behavioral Symptoms
- Behavior
- Anxiety Disorders
- Depression
- Diagnostic Techniques and Procedures
- Diagnosis
- Diagnostic Techniques, Cardiovascular
- Diagnostic Techniques, Neurological
- Heart Function Tests
- Electrodiagnosis
- Eye Movement Measurements
- Diagnostic Techniques, Ophthalmological
- Electrocardiography
- Electroencephalography
- Eye-Tracking Technology
Other Study ID Numbers
- C15-70
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Cognitive Assessments
-
Rutgers, The State University of New JerseyNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedParkinson Disease | Cognitive Decline | Parkinson | Genetic Predisposition | GBA Gene MutationUnited States
-
NYU Langone HealthCompletedSchizophrenia | Bipolar DisorderUnited States
-
Centre Hospitalier Universitaire, AmiensNot yet recruitingAutism Spectrum Disorder | Diagnosis | Social Cognition | Eye-trackingFrance
-
University Hospital, Clermont-FerrandRecruitingCancer | Neuropathic Pain | PredictiveFrance
-
ElMindA LtdTel Aviv University; Sheba Medical CenterCompletedTraumatic Brain Injury (TBI)Israel
-
Imperial College LondonRecruitingStroke | Cerebrovascular Disorders | Cognitive Impairment | Dementia, Vascular | Small Vessel Cerebrovascular Disease | Stroke (CVA) or TIAUnited Kingdom
-
Clinique Neuro-OutaouaisCogState Ltd.CompletedMultiple SclerosisCanada
-
University Hospital, CaenCompletedFractures | Accidental FallsFrance
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingAcute Myocardial Infarction | Subclinical DepressionItaly
-
Memorial Sloan Kettering Cancer CenterDr. Susan Love Research Foundation; ENFORMIA INC.Active, not recruitingBreast Cancer SurvivorsUnited States